1. Home
  2. GNE vs PGEN Comparison

GNE vs PGEN Comparison

Compare GNE & PGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNE
  • PGEN
  • Stock Information
  • Founded
  • GNE 2011
  • PGEN 1998
  • Country
  • GNE United States
  • PGEN United States
  • Employees
  • GNE N/A
  • PGEN N/A
  • Industry
  • GNE Power Generation
  • PGEN Biotechnology: Pharmaceutical Preparations
  • Sector
  • GNE Utilities
  • PGEN Health Care
  • Exchange
  • GNE Nasdaq
  • PGEN Nasdaq
  • Market Cap
  • GNE 413.5M
  • PGEN 493.0M
  • IPO Year
  • GNE N/A
  • PGEN N/A
  • Fundamental
  • Price
  • GNE $15.69
  • PGEN $4.18
  • Analyst Decision
  • GNE
  • PGEN Buy
  • Analyst Count
  • GNE 0
  • PGEN 5
  • Target Price
  • GNE N/A
  • PGEN $7.50
  • AVG Volume (30 Days)
  • GNE 226.5K
  • PGEN 15.4M
  • Earning Date
  • GNE 08-07-2025
  • PGEN 08-12-2025
  • Dividend Yield
  • GNE 1.97%
  • PGEN N/A
  • EPS Growth
  • GNE 4.51
  • PGEN N/A
  • EPS
  • GNE 0.31
  • PGEN N/A
  • Revenue
  • GNE $456,876,000.00
  • PGEN $4,340,000.00
  • Revenue This Year
  • GNE $14.60
  • PGEN $256.94
  • Revenue Next Year
  • GNE $8.64
  • PGEN $759.81
  • P/E Ratio
  • GNE $39.05
  • PGEN N/A
  • Revenue Growth
  • GNE 3.75
  • PGEN N/A
  • 52 Week Low
  • GNE $13.05
  • PGEN $0.65
  • 52 Week High
  • GNE $28.47
  • PGEN $4.21
  • Technical
  • Relative Strength Index (RSI)
  • GNE 27.83
  • PGEN 88.14
  • Support Level
  • GNE $15.19
  • PGEN $2.94
  • Resistance Level
  • GNE $16.60
  • PGEN $3.34
  • Average True Range (ATR)
  • GNE 0.82
  • PGEN 0.32
  • MACD
  • GNE -0.03
  • PGEN 0.22
  • Stochastic Oscillator
  • GNE 8.71
  • PGEN 99.00

About GNE Genie Energy Ltd. Class B Stock

Genie Energy Ltd, through its subsidiaries, operates as a retail energy provider. It serves two reportable business segments: Genie retail energy, or GRE, and Genie renewables. The Genie retail energy segment resells energy to residential and commercial consumers in the Eastern and Midwestern United States through its portfolio of various retail energy providers. The Genie renewables segment holds controlling interests in various companies engaged in the manufacturing of solar panels, solar installation design, and solar energy project management. It generates the majority of its revenue from the Genie retail energy segment.

About PGEN Precigen Inc.

Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.

Share on Social Networks: